Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study

Background Evidence for the effectiveness of linezolid in neurosurgical infections (NSIs) is growing. The comfortable oral dosage and tolerance of linezolid opens the possibility for sequential antimicrobial treatment (SAT) in stable patients after a period of intravenous treatment.